# AMJEVITA

NDC: 55513-413
Generic name: adalimumab-atto
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20230406

FDA application: BLA761024

## Active ingredients

- ADALIMUMAB: 10 mg/.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-413"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-413
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c44bd5b-4464-40a4-8933-8680950f00f2